100 %of the total number of 734 COVID-19 patients were given KOVIR Capsules across 2 independent studies saw no increase in the level of severity. In the research A66 on 30 September 2021, the rate of severe conversion in the placebo group was 2/32 or 6.25%. In the research B1000 on 12 October 2021, the rate of severe conversion was 28/194 or 14.4%.
100% of COVID-19 patients, including 7 patients with underlying health complications, given KOVIR Capsules saw a faster decrease in general symptoms such as cough, study nose, loss of taste and smell, aches and pain throughout the body, sore throat, nasal discharge, headache, chest pain … as well as group symptoms affecting the respiratory, nerves, and joints.
A shorter treatment time, i.e. until displaying no symptoms. The median time for the patients n the group using KOVIR Capsules was 4 days while it was 7 days for the group using placebos. After 5 days of treatment, 98.9%of the patients no longer display any Covid-related symptoms
The group given KOVIR Capsules saw a lower ratio regarding the use of medications such as antibiotics, expectorant, and antihistamine.
Proposal of KOVIR Capsules used on COVID-19 patients with mild or medium symptoms at home and at treatment facilities to support a quick decrease in symptoms, lower the ratio of increase in severity, lower the ratio of using medications, shorten the time of treatment, and help to lessen the pressure on the public health care system. It is recommended to use KOVIR Capsules immediately upon establishing a positive diagnosis.
KOVIR Capsules is made by Sao Thai Duong JSC (Sunstar JSC) which is a Vietnam based science and technology company with 21 years of experience in the field of herbs. The company currently has more than 100 herbal products which are sold widely in Vietnam, America, and Europe
Contact us for more infomations !